SEC Form 4 · accession 0001429863-26-000003
CME GROUP INC. · CME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ken Vroman
Officer — Chief Transformation Officer
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 4:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001156375
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock Class A | Sep 15, 2026 | A | 2,592 | $275.09 | A | 21,443 | D | |
| Common Stock Class A | Sep 15, 2026 | F | 320 | $275.09 | D | 21,123 | D | |
| Common Stock Class A | Sep 15, 2026 | F | 309 | $275.09 | D | 20,814 | D | |
| Common Stock Class A | Sep 15, 2026 | F | 274 | $275.09 | D | 20,540 | D | |
| Common Stock Class A | Sep 16, 2026 | F | 308 | $272.46 | D | 20,232 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
- F2Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.